Drugs / Guafenesin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05843669 | Jul 2023 → Sep 2024 | chronic bronchitis | American Health Research | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Guafenesin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05843669 ↗ |